Antimicrobial peptides - a part of innate immunity.
Palatsi. Riitta R; Kelhälä. Hanna-Leena HL
Key Findings
- Antimicrobial peptides are ancient molecules present in virtually all living organisms.
- Human tissues each produce a unique mix of AMPs, and LL‑37 is a major cathelicidin peptide.
- LL‑37 may play roles in neurodegenerative diseases and type‑2 diabetes, suggesting broader health relevance.
Practical Outcomes
- The main takeaway is that LL‑37 is a key part of innate immunity, but the abstract offers no specific dosing or protocol. For biohackers, the relevance is indirect: supporting the body’s natural production of LL‑37 (e.g., through vitamin D, which can up‑regulate cathelicidin) might be a modest strategy, though more research is needed.
Summary
This paper explains that antimicrobial peptides like LL‑37 are natural proteins made by many cells in our bodies to fight microbes. They vary by tissue and work because of their charge and ability to slip into microbe membranes. LL‑37 is one of the most studied and may be linked to brain diseases and type‑2 diabetes, but the article doesn’t give any direct tips on how to use it.
Abstract
Antimicrobial peptides (AMP) are evolutionary ancient molecules produced by nearly all living organisms, both prokaryotic and eukaryotic cells. More than 2000 AMPs have now been identified. These peptides are produced by most human cell types, such as those in the skin and mucous membranes and blood. Each tissue has a different spectrum of AMPs. Antimicrobial capacity depends on the structural characteristics such as charge and amphiphilicity that allow the insertion and/or penetration of AMP into the membranes of microorganisms or other cells. AMPs may have importance in the pathogenesis of neurodegenerative diseases and type 2 diabetes. The most investigated AMPs are defensins and cathelicidin LL-37.
Study Information
pubmed
2016